These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26271140)

  • 21. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
    Popovics P; Frigo DE; Schally AV; Rick FG
    Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of AMP-activated protein kinase in cancer therapy.
    Rehman G; Shehzad A; Khan AL; Hamayun M
    Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapies in metastatic esophageal cancer: advances over the past decade.
    Mohamed A; El-Rayes B; Khuri FR; Saba NF
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):186-96. PubMed ID: 24582516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
    Ong KW; Hsu A; Tan BK
    Biochem Pharmacol; 2013 May; 85(9):1341-51. PubMed ID: 23416115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells.
    Martínez-Martín N; Blas-García A; Morales JM; Marti-Cabrera M; Monleón D; Apostolova N
    Int J Mol Med; 2012 Jan; 29(1):88-94. PubMed ID: 21956774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic strategies targeting cancer--specific metabolism].
    Makinoshima H; Owada S; Esumi H
    Nihon Rinsho; 2015 Aug; 73(8):1296-301. PubMed ID: 26281681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging approaches to target tumor metabolism.
    Ross SJ; Critchlow SE
    Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer.
    Wang G; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
    Curr Cancer Drug Targets; 2019; 19(7):534-550. PubMed ID: 30360743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canonical and new generation anticancer drugs also target energy metabolism.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Hernández-Reséndiz I; Marín-Hernández A; Pacheco-Velázquez SC; López-Ramírez SY; Rumjanek FD; Moreno-Sánchez R
    Arch Toxicol; 2014 Jul; 88(7):1327-50. PubMed ID: 24792321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
    Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
    Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor glycolysis as a target for cancer therapy: progress and prospects.
    Ganapathy-Kanniappan S; Geschwind JF
    Mol Cancer; 2013 Dec; 12():152. PubMed ID: 24298908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioenergetics of cancer. Foreword.
    Rossignol R
    Biochim Biophys Acta; 2011 Jun; 1807(6):533. PubMed ID: 21419096
    [No Abstract]   [Full Text] [Related]  

  • 34. High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase.
    Adachi M; Brenner DA
    Hepatology; 2008 Feb; 47(2):677-85. PubMed ID: 18220291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapeutic targets of tumor metabolism.
    Kishton RJ; Rathmell JC
    Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell cycle and energy metabolism in tumor cells: strategies for drug therapy.
    Amoedo ND; El-Bacha T; Rodrigues MF; Rumjanek FD
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):15-25. PubMed ID: 21110821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
    Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
    Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin inhibits Ec109 cell growth via an AMPK-mediated metabolic switch.
    Zhang FJ; Zhang HS; Liu Y; Huang YH
    Life Sci; 2015 Aug; 134():49-55. PubMed ID: 26037398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.